A hub of pharma innovation : LSIPR CONFERENCE SPECIAL 2016
Practices:Patents
Category:Others
| Authors | YAMAMOTO, Osamu |
|---|---|
| Practice Areas | Patents |
| Date of publication | June 2016 |
| Publication carrying this article | LSIPR CONFERENCE SPECIAL 2016 |
| Publisher | LSIPR LIFE SCIENCE INTELLECTUAL PROPERTY REVIEW |
Summary
Over the past few years there have been a number of IP developments in the pharma and biotech industries in Japan, including on patent term extension and product-by-process claims. Osamu Yamamoto of Yuasa and Hara provides a roundup.
Other works by YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Cases
The gray area between patent rights and physician practice
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Cases
Antibody Patenting – Second Edition –
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
Pharmaceutical Test Data Exclusivity
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
IP law in Japan : the recent changes
YAMAMOTO, Osamu
-
Publications
2022 – Study Question “Patentability of Diagnostic Methods”
YAMAMOTO, Osamu
Other works on Patents
-
Publications Intellectual Property、Patents Laws
Future of the Patent Attorney Industry and Use of AI – Joining the magazine discussions (considering the viewpoints on AI’s technological future) –
OKAMOTO, Yoshinori
-
Publications Intellectual Property、Patents Laws
The Amount of Damages Recoverable by Joint Patentees for Patent Infringement
FUKAI, Toshiyuki
-
Publications Intellectual Property、Patents Cases
The gray area between patent rights and physician practice
YAMAMOTO, Osamu
-
Publications Intellectual Property、Patents Laws
Article 102(2) of the Patent Act – The Necessity of Sale of Competitive Products by Patentees
FUKAI, Toshiyuki
-
Publications Intellectual Property、Patents Laws
The Effect of an Invention
FUKAI, Toshiyuki
Telephone
+81(3)3270-6641